Obstetrics & Gynecology Doctors in Kailua Kona, HI Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Dr. Ken R Clayton, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 78-6831 Alii Dr Ste 411, Kailua Kona, HI 96740 Phone: 808-747-8321

Kristen O. Goerg, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 74-517 Honokohau St, Kailua Kona, HI 96740 Phone: 808-334-4400

Dr. Christina Collins, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 75-5759 Kuakini Hwy, Suite 202, Kailua Kona, HI 96740 Phone: 808-331-2300

Dr. Melissa C. Smith, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 75-184 Hualalai Rd, Kailua Kona, HI 96740 Phone: 808-334-4400

Aries Kuo, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 78-6831 Alii Dr Ste 411, Kailua Kona, HI 96740 Phone: 088-747-8322

Dr. Harnath Christopher Holmes, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 78-6831 Alii Dr, Suite 422, Kailua Kona, HI 96740 Phone: 808-747-8321

Mark S. Rhee, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 74-517 Honokohau St, Kailua Kona, HI 96740 Phone: 808-334-4400

News Archive

ViewRay to exhibit MRI-guided radiation therapy system at ESTRO Forum

ViewRay, makers of the world's first and only MRI-guided radiation therapy system, announced today that the company will showcase its MRIdian System at the 3rd ESTRO Forum, the annual meeting of the European Society for Radiotherapy and Oncology, being held April 24-28, 2015 in Barcelona, Spain.

Lack of 'systematic reviews' in stroke research lead to waste of time, resources

Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.

Preliminary results of WebMD Health's tender offer

WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 5,700,000 shares of its common stock at a price of $37.00 per share, which expired at 5:00 p.m., New York City time on December 10, 2009.

UK government announces deals to secure two new COVID-19 treatments

Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government announced deals to secure two new treatments.

Sorrento receives funding to advance immunotherapy targeting WISP1 for treatment of IPF

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.

Read more Medical News

› Verified 5 days ago